Stock comparison
BECTON DICKINSON & CO is 12.2x more valuable than HAEMONETICS CORP by market capitalization ($41.57 B vs $3.41 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
BDX is larger
BECTON DICKINSON & CO is 12.2x more valuable than HAEMONETICS CORP by market capitalization ($41.57 B vs $3.41 B).
Market value leader
BDX
BECTON DICKINSON & CO is 12.2x more valuable than HAEMONETICS CORP by market capitalization ($41.57 B vs $3.41 B).
Revenue leader
BDX
HAE: $1.33B vs BDX: $21.84B.
Profit leader
BDX
HAE: $97.31M vs BDX: $1.68B.
Margin leader
BDX
HAE: 7.3% vs BDX: 7.7% net margin.
| Metric | HAE | BDX |
|---|---|---|
| Market cap | $3.41 B | $41.57 B |
| US-listed rank | #1725 | #373 |
| Revenue (latest FY) | $1.33B | $21.84B |
| Net income (latest FY) | $97.31M | $1.68B |
| Net margin | 7.3% | 7.7% |
| P/E (trailing FY) | 35.0x | 24.8x |
| SEC filings | 1,875 | 3,027 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
BECTON DICKINSON & CO is 12.2x more valuable than HAEMONETICS CORP by market capitalization ($41.57 B vs $3.41 B).
In their latest fiscal years, HAEMONETICS CORP reported $1.33B in revenue while BECTON DICKINSON & CO reported $21.84B.
Full pages: HAEMONETICS CORP and BECTON DICKINSON & CO, or browse the full rankings.